Efficient siRNA targeted delivery into cancer cells by gastrin-releasing peptides

Bioconjugate Chemistry

Volumn 23, Issue 5, 2012, Pages 1040-1049

  Sioud, Mouldy ^a   Mobergslien, Anne ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CELL CULTURE; CELL PROLIFERATION; DISEASES; GENE EXPRESSION; RNA;

CANCER CELLS; CELL POPULATIONS; CELLULAR UPTAKE; HUMAN BLOODS; MAMMARY EPITHELIAL CELLS; MDA-MB-231; PEPTIDE RECEPTOR; SMALL INTERFERING RNA; SURVIVIN; TARGETED DELIVERY;

PEPTIDES;

GASTRIN RELEASING PEPTIDE; GASTRIN RELEASING PEPTIDE GONADOTROPIN RELEASING HORMONE SMALL INTERFERING RNA CONJUGATE; GASTRIN RELEASING PEPTIDE RECEPTOR; GASTRIN RELEASING PEPTIDE SMALL INTERFERING RNA CONJUGATE; GONADORELIN; GONADORELIN RECEPTOR; SMALL INTERFERING RNA; SURVIVIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG BINDING; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG TARGETING; DRUG UPTAKE; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RNA INTERFERENCE;

BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GASTRIN-RELEASING PEPTIDE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; RECEPTORS, BOMBESIN; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84861123795     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300050j     Document Type: Article

References (46)

1. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411, 494-498
2. Behlke, M. A. (2006) Progress towards in vivo use of siRNAs Mol. Ther. 13, 644-670
3. Lares, M. R., Rossi, J. J., and Ouellet, D. L. (2010) RNAi and small interfering RNAs in human disease therapeutic applications Trends Biotechnol. 28, 129-138
4. Sioud, M. (2005) On the delivery of small interfering RNAs into mammalian cells Expert Opin. Drug Delivery 2, 639-651
5. Mykhaylyk, O., Zelphati, O., Rosenecker, J., and Plank, C. (2008) siRNA delivery by magnetofection Curr. Opin. Mol. Ther. 10, 493-505
6. Torchilin, V. P., Rammohan, R., Wissig, V., and Levchenko, T. S. (2001) TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors Proc. Natl. Acad. Sci. U.S.A. 98, 8786-8791
7. Morris, M. C., Vidal, P., Chaloin, L., Heitz, F., and Divita, G. (1997) A new peptide vector for efficient delivery of oligonucleotides into mammalian cells Nucleic Acids Res. 25, 2730-2736
8. Derossi, D., Joliot, A. H., Chassaing, G., and Prochiantz, A. (1994) The third helix of the antennapedia homeodomain translocates through biological membranes J. Biol. Chem. 269, 10444-10450
9. Ishihara, T., Goto, M., Kodera, K., Kanazawa, H., Murakami, Y., Mizushima, Y., and Higaki, M. (2009) Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides Drug Delivery 16, 153-159
10. Meade, B. R. and Dowdy, S. F. (2007) Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides Adv. Drug Delivery Rev. 59, 134-140
11. Song, E., Zhu, P., Lee, S. K., Chowdhury, D., Kussmann, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., Marasco, W. A., and Lieberman, J. (2005) Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors Nat. Biotechnol. 23, 709-717
12. Kortylewski, M., Swiderski, P., Herrmann, A., Wang, L., Kowolik, C., Kujawski, M., Lee, H., Scuto, A., Liu, Y., Yang, C., Deng, J., Soifer, H. S., Raubitschek, A., Forman, S., Rossi, J. J., Pardoll, D. M., Jove, R., and Yu, H. (2009) In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses Nat. Biotechnol. 27, 925-932
13. McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, E. R., Gilboa, E., Sullenger, B. A., and Giangrande, P. H. (2006) Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras Nat. Biotechnol. 24, 1005-1015
14. Cesarone, G., Edupuganti, O. P., Chen, C. P., and Wickstrom, E. (2007) Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged d -peptide analogue of insulin-like growth factor 1 Bioconjugate Chem. 18, 1831-1840
15. Kumar, P., Wu, H., McBride, J. L., Jung, K. E., Kim, M. H., Davidson, B. L., Le, S. K., Shankar, P., and Manjunath, N. (2007) Transvascular delivery of small interfering RNA to the central nervous system Nature 448, 39-43
16. Peer, D., Zhu, P., Carman, C. V., Lieberman, J., and Shimaoka, M. (2007) Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1 Proc. Natl. Acad. Sci. U.S.A. 104, 4095-4100
17. McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, E. R., Gilboa, E., Sullenger, B. A., and Giangrande, P. H. (2006) Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras Nat. Biotechnol. 24, 1005-1015
18. Pasqualini, R. and Ruoslahti, E. (1996) Organ targeting in vivo using phage display peptide libraries Nature 380, 364-366
19. Shadidi, M. and Sioud, M. (2003) Selective targeting of cancer cells using synthetic peptides Drug Resist. Updates 6, 363-371
20. Shadidi, M. and Sioud, M. (2003) Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells FASEB J. 17, 256-258
21. Wang, X. F., Birringer, M., Dong, L. F., Veprek, P., Low, P., Swettenham, E., Stantic, M., Yuan, L. H., Zobalova, R., Wu, K., Ledvina, M., Ralph, S. J., and Neuzil, J. (2007) A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression Cancer Res. 67, 3337-3344
22. Luo, H., Yang, J., Jin, H., Huang, C., Fu, J., Yang, F., Gong, H., Zeng, S., Luo, Q., and Zhang, Z. (2011) Tetrameric far-red fluorescent protein as a scaffold to assemble an octavalent peptide nanoprobe for enhanced tumor targeting and intracellular uptake in vivo FASEB J. 25, 1-9
23. Schiffelers, R. M., Ansari, A., Xu, J., Zhou, Q., Tang, Q., Storm, G., Molema, G., Lu, P. Y., Scaria, P. V., and Woodle, M. C. (2004) Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle Nucleic Acids Res. 32, e149
24. Moschos, S. A., Jones, S. W., Perry, M. M., Williams, A. E., Erjefalt, J. S., Turner, J. J., Barnes, P. J., Sproat, B. S., Gait, M. J., and Linda, M. A. (2007) Lung delivery studies using siRNA conjugated to TAT (48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity Bioconjugate Chem. 18, 1450-1459
25. Riccabona, G. and Decristoforo, C. (2003) Peptide targeted imaging of cancer Cancer Biother. Radiopharm. 18, 675-687
26. Preston, S. R., Woodhouse, L. F., Jones-Blackett, S., Miller, G. V., and Primrose, J. N. (1995) High-affinity binding sites for gastrin-releasing peptide on human colorectal cancer tissue but not uninvolved mucosa Br. J. Cancer 71, 1097-1089
27. Smith, C. J., Volkert, W. A., and Hoffman, T. J. (2003) Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update Nucl. Med. Biol. 30, 861-868
28. Smith, C. J., Volkert, W. A., and Hoffman, T. J. (2005) Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes Nucl. Med. Biol. 32, 733-740
29. Montagnani-Marelli, M., Moretti, R. M., Januszkiewcz-Caulier, J., Motta, M., and Limonata, P. (2006) Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients? Curr. Cancer Drug Targets 6, 257-269
30. Schumann, M., Nakagawa, T., Mantey, S. A., Howell, B., and Jensen, R. T. (2008) Function of non-visual arrestins in signalling and endocytosis of the gastrin-releasing peptide receptor (GRP receptor) Biochem. Pharmacol. 75, 1170-1185
31. Flatekval, G. F. and Sioud, M. (2009) Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase Immunology 128, e837-e848
32. Muratovska, A. and Eccles, M. R. (2004) Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells FEBS Lett. 558, 63-68
33. Davidson, T. J., Harel, S., Arboleda, V. A., Prunel, G. F., Shelanski, M. L, Greene, L. A., and Troy, C. M. (2004) Highly efficient small interfering RNA delivery to primary mammalian neurons induces microRNA-like effects before mRNA degradation J. Neurosci. 24, 10040-10046
34. Patel, O., Shulkes, A., and Baldwin, G. S. (2006) Gastrin-releasing peptide and cancer Biochim. Biophys. Acta 1766, 23-41
35. Altieri, D. C. (2008) Survivin, cancer networks and pathway-directed drug discovery Nat. Rev. Cancer 8, 61-70
36. Sioud, M. (2005) Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization J. Mol. Biol. 348, 1079-1090
37. Sioud, M. (2007) RNA interference and innate immunity Adv. Drug Delivery Rev. 59, 153-163
38. Rudnick, S. I. and Adams, G. P. (2009) High affinity antibody for targeting. Affinity and avidity in antibody-based tumor targeting Cancer Biother. Radiopharm. 24, 155-161
39. Xia, C. F., Zhang, Y., Zhang, Y., Boado, R. J., and Pardridge, W. M. (2007) Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology Pharmacol. Res. 24, 2309-2316
40. Van de Wiele, C., Dumont, F., Broecke, R. V., Oosterlinck, W., Cocquyt, V., Serrenyn, R., Peers, S., Thornback, J., Slegers, G., and Dierckx, R. A. (2000) Technetium-99m RP527, a GRP analogue for visualization of GRP receptor-expressing malignancies: a feasible study Eur. J. Nucl. Med. 27, 1694-1699
41. Alam, M. R., Ming, X., Fischer, M., Lackey, J. G., Rajeev, K. G., Manoharan, M., and Juliano, R. L. (2011) Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA Bioconjugate Chem. 22, 1673-1681
42. Tumer, J. J., Jones, S., Fabani, M. M., Ivanova, G., Arzumanov, A. A., and Gait, M. J. (2007) RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA Blood Cells, Mol. Dis. 38, 1-7
43. Hong, J., Huang, Y., Li, J., Yi, F., Zheng, J., Huang, H., Wei, N., Shan, Y., An, M., Zhang, H., Ji, J., Zhang, P., Xi, Z., Du, Q., and Liang, Z. (2010) Comprehensive analysis of sequence-specific stability of siRNA FASEB J. 24, 4844-4855
44. Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., and MacLachlan, I. (2005) Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA Nat. Biotechnol. 23, 457-462
45. Furset, G. and Sioud, M. (2007) Design of bifunctional siRNAs: combining immunostimulation and gene-silencing in one single siRNA molecule Biochem. Biophys. Res. Commun. 352, 642-649
46. Jeong, J. H., Mok, H, Oh, Y.-K., and Park, T. G. (2009) siRNA conjugate delivery systems Bioconjugate Chem. 20, 5-14